Trial Site Detail

 

Drug:
Vorinostat + Bortezomib
Trial:
Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors
Conditions: Solid Tumors
Trial Status:
Completed

 

Carbone Cancer Center, University of Wisconsin

     
Madison , WI 53792
USA

 

Principal Investigator:
 George Wilding, MD
Contact:
 Clinical Trials Office 608-262-5223
Activation Status of this Site:
 Closed
Notes about this Site:
Carbone Cancer Center, University of Wisconsin Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.